Published 6/15/2026
As interest in orthobiologics continues to grow across sports medicine and orthopaedic practice, the AAOS Biologics Symposium returns on July 8 in Seattle as a full-day, in-person, premeeting program held in conjunction with the American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting. Encompassing evidence, innovation, and real-world application, the 2026 symposium will offer attendees a comprehensive look at the current state and future direction of biologics in musculoskeletal care.
A timely theme for a rapidly evolving field
This year’s program, “OrthoBiologics and the Modern Athlete: Optimizing Evidence, Recovery, and Return to Play,” reflects the increasing demand for clear, evidence-based guidance in a space often marked by rapid innovation and evolving regulatory considerations. Through expert-led sessions, attendees will explore how biologic therapies are being evaluated, applied, and integrated into clinical decision making, particularly in the care of athletic and active patient populations.
The symposium is designed to move beyond theory, emphasizing practical insights clinicians can apply today while also addressing where the science is headed next. Sessions will highlight emerging research, real-world outcomes, and ongoing challenges in translating biologics from bench to bedside.
Keynote perspective from the front lines of sports medicine
Headlining the program is keynote speaker Thom Mayer, MD, medical director of the NFL Players Association. With a career spanning emergency medicine, sports medicine, and leadership at the highest levels of professional athletics, Dr. Mayer brings a unique perspective on athlete care, performance, and recovery to biologics. His address will draw on decades of experience managing complex medical decisions in high-stakes environments, offering insights relevant to clinicians across practice settings.
Designed for engagement and connection
Held as a premeeting program, the AAOS Biologics Symposium offers attendees an opportunity to begin their AOSSM Annual Meeting experience with focused, specialty-driven education without additional travel or logistics. The in-person format also fosters meaningful discussion, peer exchange, and direct engagement with faculty leaders shaping the future of orthobiologics.
Whether attendees are longtime users of biologic therapies or seeking clarity in a complex and fast-moving field, the symposium is structured to meet clinicians where they are, providing balanced perspectives grounded in evidence and clinical reality.
Advancing education, improving outcomes
As biologics continue to influence treatment strategies across orthopaedics and sports medicine, the AAOS Biologics Symposium remains a cornerstone educational offering, supporting informed decision making and improved patient outcomes. By bringing together expert voices, current research, and practical insights, the 2026 program aims to equip attendees with the knowledge and confidence to navigate this evolving landscape.
Registration is now open, and early registration is encouraged for this highly anticipated program.